PeptideClinicLocatorOverview
GHRP-6 is a growth hormone releasing peptide that stimulates GH release and appetite. It has been marketed for GH support and anti-aging. GHRP-6 is prohibited for compounding in the US—there is no pathway. It is not FDA-approved. Evidence is moderate (limited human studies). For legal GH support, sermorelin is the appropriate compoundable option.
How It Works (Mechanism of Action)
GHRP-6 stimulates growth hormone release and can increase appetite. Mechanism is similar in concept to GHRP-2 but with different receptor affinity and effects.
Primary Uses
Marketed for GH stimulation, appetite stimulation, and anti-aging. Not legal for compounding.
FDA & Regulatory Status
Prohibited for compounding. No pathway. Not FDA-approved.
Last reviewed February 2026.
Clinical Evidence
Moderate—limited human studies.
Side Effects & Safety
Increased appetite and injection site reactions. Not legally available in the US.
